BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plöthner M, Frank M, von der Schulenburg JG. Cost analysis of whole genome sequencing in German clinical practice. Eur J Health Econ 2017;18:623-33. [PMID: 27380512 DOI: 10.1007/s10198-016-0815-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
2 Christensen KD, Phillips KA, Green RC, Dukhovny D. Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project. Value Health 2018;21:1054-61. [PMID: 30224109 DOI: 10.1016/j.jval.2018.06.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 Bayle A, Droin N, Besse B, Zou Z, Boursin Y, Rissel S, Solary E, Lacroix L, Rouleau E, Borget I, Bonastre J. Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting. Eur J Health Econ 2021;22:855-64. [PMID: 33765190 DOI: 10.1007/s10198-021-01293-1] [Reference Citation Analysis]
4 Pasmans CTB, Tops BBJ, Steeghs EMP, Coupé VMH, Grünberg K, de Jong EK, Schuuring EMD, Willems SM, Ligtenberg MJL, Retèl VP, van Snellenberg H, de Bruijn E, Cuppen E, Frederix GWJ. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing. Expert Rev Pharmacoecon Outcomes Res 2021;21:413-4. [PMID: 33852815 DOI: 10.1080/14737167.2021.1917385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med 2018;20:1122-30. [PMID: 29446766 DOI: 10.1038/gim.2017.247] [Cited by in Crossref: 197] [Cited by in F6Publishing: 171] [Article Influence: 49.3] [Reference Citation Analysis]
6 Weymann D, Laskin J, Roscoe R, Schrader KA, Chia S, Yip S, Cheung WY, Gelmon KA, Karsan A, Renouf DJ, Marra M, Regier DA. The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers. Mol Genet Genomic Med 2017;5:251-60. [PMID: 28546995 DOI: 10.1002/mgg3.281] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
7 Hochstenbach R, van Binsbergen E, Schuring-Blom H, Buijs A, Ploos van Amstel HK. A survey of undetected, clinically relevant chromosome abnormalities when replacing postnatal karyotyping by Whole Genome Sequencing. Eur J Med Genet 2019;62:103543. [PMID: 30248410 DOI: 10.1016/j.ejmg.2018.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Marino P, Touzani R, Perrier L, Rouleau E, Kossi DS, Zhaomin Z, Charrier N, Goardon N, Preudhomme C, Durand-Zaleski I, Borget I, Baffert S; NGSEco Group:. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study. Eur J Hum Genet 2018;26:314-23. [PMID: 29367707 DOI: 10.1038/s41431-017-0081-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
9 Plöthner M, Frank M, Graf von der Schulenburg JM. [Whole-genome sequencing in German clinical practice : Economic impacts of its use in selected areas of application]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2017;60:143-50. [PMID: 27999872 DOI: 10.1007/s00103-016-2492-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Gong J, Pan K, Fakih M, Pal S, Salgia R. Value-based genomics. Oncotarget 2018;9:15792-815. [PMID: 29644010 DOI: 10.18632/oncotarget.24353] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
11 Simons M, Van De Ven M, Coupé V, Joore M, IJzerman M, Koffijberg E, Frederix G, Uyl-De Groot C, Cuppen E, Van Harten W, Retèl V. Early technology assessment of using whole genome sequencing in personalized oncology. Expert Rev Pharmacoecon Outcomes Res 2021;21:343-51. [PMID: 33910430 DOI: 10.1080/14737167.2021.1917386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Laviolle B, Denèfle P, Gueyffier F, Bégué É, Bilbault P, Espérou H, Gaillard-bigot F, Grenet G, Guérin J, Guillot C, Longeray P, Morere J, Perche O, Perrier L, Sanlaville D, Thevenon J, Varoqueaux N. The contribution of genomics in the medicine of tomorrow, clinical applications and issues. Therapies 2019;74:9-15. [DOI: 10.1016/j.therap.2018.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Helguera M. Sequencing and Assembling Genomes and Chromosomes of Cereal Crops. Methods Mol Biol 2020;2072:27-37. [PMID: 31541436 DOI: 10.1007/978-1-4939-9865-4_4] [Reference Citation Analysis]
14 van de Ven M, Koffijberg H, Retèl V, Monkhorst K, Smit E, van Harten W, IJzerman M. Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals. J Mol Diagn 2021;23:484-94. [PMID: 33493663 DOI: 10.1016/j.jmoldx.2021.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Pritikin JN, Schmitt JE, Neale MC. Cloud computing for voxel-wise SEM analysis of MRI data. Struct Equ Modeling 2019;26:470-80. [PMID: 31133771 DOI: 10.1080/10705511.2018.1521285] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Gordon LG, White NM, Elliott TM, Nones K, Beckhouse AG, Rodriguez-Acevedo AJ, Webb PM, Lee XJ, Graves N, Schofield DJ. Estimating the costs of genomic sequencing in cancer control. BMC Health Serv Res 2020;20:492. [PMID: 32493298 DOI: 10.1186/s12913-020-05318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Costa SS, Guimarães LC, Silva A, Soares SC, Baraúna RA. First Steps in the Analysis of Prokaryotic Pan-Genomes. Bioinform Biol Insights 2020;14:1177932220938064. [PMID: 32843837 DOI: 10.1177/1177932220938064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]